TrialDrug design, development and therapy2016

Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment).

Tadakatsu Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.